Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Non-syndromic retinal dystrophy associated with biallelic mutation of SUMF1 and reduced leukocyte sulphatase activity
Author Affiliations & Notes
  • Siying Lin
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    UCL Institute of Ophthalmology, University College London, London, United Kingdom
  • Anthony G Robson
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    UCL Institute of Ophthalmology, University College London, London, United Kingdom
  • Dorothy A Thompson
    Tony Kriss Visual Electrophysiology Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, London, United Kingdom
  • Derek Burke
    Enzyme laboratory, Great Ormond Street Hospital for Children NHS Foundation Trust, London, London, United Kingdom
  • Robin Lachmann
    Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London, United Kingdom
  • Emma Footitt
    Department of Metabolic Paediatrics, Great Ormond Street Hospital for Children NHS Foundation Trust, London, London, United Kingdom
  • Karolina M Stepien
    Adult Inherited Metabolic Disorders, Northern Care Alliance NHS Foundation Trust Salford Care Organisation, Salford, United Kingdom
  • Elena Schiff
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    UCL Institute of Ophthalmology, University College London, London, United Kingdom
  • Michel Michaelides
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    UCL Institute of Ophthalmology, University College London, London, United Kingdom
  • Omar Abdul Rahman Mahroo
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    UCL Institute of Ophthalmology, University College London, London, United Kingdom
  • Gavin Arno
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    UCL Institute of Ophthalmology, University College London, London, United Kingdom
  • Andrew Webster
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    UCL Institute of Ophthalmology, University College London, London, United Kingdom
  • Footnotes
    Commercial Relationships   Siying Lin None; Anthony Robson None; Dorothy Thompson None; Derek Burke None; Robin Lachmann None; Emma Footitt None; Karolina Stepien None; Elena Schiff None; Michel Michaelides None; Omar Mahroo None; Gavin Arno None; Andrew Webster None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1521. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Siying Lin, Anthony G Robson, Dorothy A Thompson, Derek Burke, Robin Lachmann, Emma Footitt, Karolina M Stepien, Elena Schiff, Michel Michaelides, Omar Abdul Rahman Mahroo, Gavin Arno, Andrew Webster; Non-syndromic retinal dystrophy associated with biallelic mutation of SUMF1 and reduced leukocyte sulphatase activity. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1521.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Biallelic variants in the SUMF1 gene are associated with multiple sulfatase deficiency (MSD), a rare lysosomal storage disorder typically diagnosed in infancy or childhood and marked by severe neurodegeneration and early mortality. In this study, we present a detailed clinical and molecular characterisation of three patients with milder clinical manifestations due to SUMF1 disease variants.

Methods : Whole genome sequencing (WGS) was performed for two adult patients (patients 1 and 2) aged 34 and 54 years with non-syndromic retinal dystrophy. A third patient aged 7 years with retinal dystrophy and an attenuated metabolic phenotype was later identified through clinical collaboration.

Results : Patients 1 and 2 had reduced visual acuities documented at hand motion and 3/60 Snellen, respectively. Fundus examination showed central macular atrophy with mixed hypo- and hyper-autofluorescent changes at the posterior pole, with outer retinal disruption on optical coherence tomography. Systems review identified no MSD-associated extraocular features.

Patient 3 featured a mild neurological presentation primarily characterised by autism. Additional associated features of MSD included oral aversion and feeding difficulties, short stature, and recurrent ear and throat infections. His visual acuity was maintained at 6/7.5 bilaterally, with only mild pigmentary mottling observed on fundus examination. ERGs in all three patients indicated a rod-cone dystrophy with additional possible inner retinal dysfunction, with severe macular involvement also noted in patients 1 and 2.

WGS identified biallelic SUMF1 variants in all three patients; patient 1 was homozygous for a complex allele c.[290G>T;293T>A]; p.[(Gly97Val);Val98Glu)], patient 2 was homozygous for c.866A>G; p.(Tyr289Cys), and patient 3 was compound heterozygous for c.726-1G>C and p.(Tyr289Cys). Biochemical studies confirmed reduced, but not abrogated, sulfatase enzyme activity in all three patients in the absence of extra-ocular disease or only mild systemic disease in patient 3.

Conclusions : These cases are suggestive that non-null genotypes in SUMF1 can cause an attenuated clinical phenotype including retinal dystrophy, without systemic complications in adulthood. Two of the three alleles observed here, not previously reported in MSD, are likely to confer reduced but not abrogated SUMF1 protein function.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×